CompletedPhase 2NCT02343224
Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
Studying Classic pilocytic astrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Emory University
- Principal Investigator
- Dolly Aguilera, MDChildren's Healthcare of Atlanta/Emory University
- Intervention
- Pegylated interferon alpha-2b(drug)
- Enrollment
- 9 enrolled
- Eligibility
- 3-25 years · All sexes
- Timeline
- 2014 – 2020
Study locations (1)
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Collaborators
CURE Childhood Cancer, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02343224 on ClinicalTrials.govOther trials for Classic pilocytic astrocytoma
Additional recruiting or active studies for the same condition.